Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED | N.MMED.WA | N.MMED.WR

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Liquidtrade if everything is a joke

<< Previous

Bullboard Posts

Next >>

Comment by Liquidtradeon Dec 18, 2020 1:51pm

181 Views

Post# 32141192

RE:Liquidtrade if everything is a joke

armordeck wrote: why don't you short it

I never said it was a joke, you moron.

Learn how to read a post...and learn how to use the "quote" feature, FVck wit

I said I was long on this thing since .58 cents and I was responding to another poster who was the one who said this stock was a joke.

My god, dude. For Christmas, plz think about sticking your head in the oven.

<< Previous

Bullboard Posts

Next >>

Rock Tech notches official permit for German lithium refinery